ValiRx - Q&A session
VAL
Thu, 28 Sep 2023, 07:00am BST
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Industry: Health Care
Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/
Dr Suzanne Dilly and Dr Kevin Cox host a Q&A session where they answer shareholder questions.
